Literature DB >> 11418660

The Sushi domain of soluble IL-15 receptor alpha is essential for binding IL-15 and inhibiting inflammatory and allogenic responses in vitro and in vivo.

M Orchardson, J A Gracie, B P Leung, H Guan, W Niedbala, G K Paterson, I B McInnes, F Y Liew.   

Abstract

IL-15 is a pleiotropic cytokine that plays important roles in both innate and adaptive immunity. It is associated with a range of immunopathology, including rheumatoid arthritis and allograft rejection. IL-15 functions through the trimeric IL-15R complex, which consists of a high affinity binding alpha-chain and the common IL-2R beta- and gamma-chains. Characterization of IL-15/IL-15R interactions may facilitate the development of improved IL-15 antagonists for therapeutic interventions. We previously constructed soluble murine IL-15Ralpha (sIL-15Ralpha) by deleting the cytoplasmic and transmembrane domains. To localize the functional domain of IL-15Ralpha, we have now constructed various truncated versions of sIL-15Ralpha. The shortest region retaining IL-15 binding activity is a 65-aa sequence spanning the Sushi domain of IL-15Ralpha. Sushi domains, common motifs in protein-protein interactions, contain four cysteines forming two disulfide bonds in a 1-3 and 2-4 pattern. Amino acid substitution of the first or fourth cysteine in sIL-15Ralpha completely abolished its IL-15 binding activity. This also abrogated the ability of sIL-15Ralpha to neutralize IL-15-induced proinflammatory cytokine production and anti-apoptotic response in vitro. Furthermore, the mutant sIL-15Ralpha lost its ability to inhibit carrageenan-induced local inflammation and allogenic cell-induced T cell proliferation and cytokine production in vivo. Thus, the Sushi domain is critical for the functional activity of sIL-15Ralpha.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11418660     DOI: 10.4049/jimmunol.167.1.277

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  In Vivo Activation of Human NK Cells by Treatment with an Interleukin-15 Superagonist Potently Inhibits Acute In Vivo HIV-1 Infection in Humanized Mice.

Authors:  Kieran Seay; Candice Church; Jian Hua Zheng; Kathryn Deneroff; Christina Ochsenbauer; John C Kappes; Bai Liu; Emily K Jeng; Hing C Wong; Harris Goldstein
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

2.  Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}.

Authors:  Mark P Rubinstein; Marek Kovar; Jared F Purton; Jae-Ho Cho; Onur Boyman; Charles D Surh; Jonathan Sprent
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-06       Impact factor: 11.205

3.  Lack of IL-15 results in the suboptimal priming of CD4+ T cell response against an intracellular parasite.

Authors:  Crescent L Combe; Magali M Moretto; Joseph D Schwartzman; Jason P Gigley; David J Bzik; Imtiaz A Khan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-13       Impact factor: 11.205

4.  Interleukin-15 and its receptor (IL-15Rα) serve as new therapeutic implications for Behçet's disease.

Authors:  Yong He; Cheng Huang; Bao-Ming Wu; Jun Li
Journal:  Rheumatol Int       Date:  2013-09-18       Impact factor: 2.631

5.  A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium.

Authors:  Weihong Tang; Martina Teichert; Daniel I Chasman; John A Heit; Pierre-Emmanuel Morange; Guo Li; Bruno H Ch Stricker; Paul M Ridker; Aaron R Folsom; Nicholas L Smith; Nathan Pankratz; Frank W Leebeek; Guillaume Paré; Mariza de Andrade; Christophe Tzourio; Bruce M Psaty; Saonli Basu; Rikje Ruiter; Lynda Rose; Sebastian M Armasu; Thomas Lumley; Susan R Heckbert; André G Uitterlinden; Mark Lathrop; Kenneth M Rice; Mary Cushman; Albert Hofman; Jean-Charles Lambert; Nicole L Glazer; James S Pankow; Jacqueline C Witteman; Philippe Amouyel; Joshua C Bis; Edwin G Bovill; Xiaoxiao Kong; Russell P Tracy; Eric Boerwinkle; Jerome I Rotter; David-Alexandre Trégouët; Daan W Loth
Journal:  Genet Epidemiol       Date:  2013-05-05       Impact factor: 2.135

6.  Tissue distribution and functional analysis of Sushi domain-containing protein 4.

Authors:  Zhidan Tu; Mark Cohen; Hong Bu; Feng Lin
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

7.  Interleukin-15:Interleukin-15 receptor α scaffold for creation of multivalent targeted immune molecules.

Authors:  Richard L Wong; Bai Liu; Xiaoyun Zhu; Lijing You; Lin Kong; Kai-Ping Han; Hyung-Il Lee; Pierre-Andre Chavaillaz; Moonsoo Jin; Yi Wang; Peter R Rhode; Hing C Wong
Journal:  Protein Eng Des Sel       Date:  2010-12-21       Impact factor: 1.650

8.  Discovery of genetic difference between asthmatic children with high IgE level and normal IgE level by whole genome linkage disequilibrium mapping using 763 autosomal STR markers.

Authors:  Jiu-Yao Wang; Cherry Guan-Ju Lin; Monica Shian-Jy Bey; Lingmei Wang; Felicia Yi-Fang Lin; Lichih Huang; Lawrence Shih-Hsin Wu
Journal:  J Hum Genet       Date:  2005-05-21       Impact factor: 3.172

9.  Binding properties of the regulatory domains in Manduca sexta hemolymph proteinase-14, an initiation enzyme of the prophenoloxidase activation system.

Authors:  Yang Wang; Haobo Jiang
Journal:  Dev Comp Immunol       Date:  2009-11-29       Impact factor: 3.636

10.  Expression of interleukin-15 and its receptor on the surface of stimulated human umbilical vein endothelial cells.

Authors:  Xiuping Liu; Yumei Zuo; Weina Zhang; Deguang Yang; Changyun Xiong; Xiaozhou Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.